Shields Health Solutions Partners with Major Academic Medical Center to Expand Specialty Pharmacy Services
STOUGHTON, Mass.--(BUSINESS WIRE)-- Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced it has partnered with Duke Health, a leading academic health system in North Carolina with a vision to further enhance health outcomes across the region by advancing clinical care.
The Duke Specialty Pharmacy expansion is designed to better support patients through lower costs, broader treatment options, and enhanced medication management. Patients filling their prescriptions at Duke Specialty Pharmacy will receive personalized, patient-centered care, including increased medication adherence, regular follow ups, side effects management, access to financial assistance, and medication delivery. Additionally, Shields' expansive access to payer networks and available drugs will give patients more choice in their specialty pharmacy and allow them to receive services through Duke Specialty Pharmacy.
The Duke Specialty Pharmacy program will bring enhanced operational efficiency and expanded support services, ensuring comprehensive care for patients with complex chronic conditions. Additionally, the program aims to include more patient populations in the future to help expand access to care.
'Our partnership with Duke Health underscores the health system's unwavering commitment to providing superior patient care and differentiated patient experiences,' said Michael Ham, CEO of Shields Health Solutions. 'We look forward to working alongside Duke Health as it expands its specialty pharmacy services and its impact on complex patients in the greater Raleigh – Durham community."
Shields currently partners with nearly 80 health systems around the country, helping patients to reduce co-pays, promptly receive medication delivery, and improve medication adherence.
About Shields Health Solutions
Shields Health Solutions (Shields) is the premier specialty pharmacy accelerator in the country. The Shields Performance Platform, an integrated set of solutions, services and technology, is intentionally designed to elevate payer and drug access for specialty pharmacies, elevate health outcomes for complex patients, and elevate growth throughout the entire health system. As the foremost experts in the health system specialty pharmacy industry, Shields has a proven track record of success including access to over 80 percent of all limited distribution drugs (LDDs) and most (health insurance) payers in the nation; and a clinical model proven to lower total cost of care by 13%. In partnership with nearly 80 health systems across the country through national-scale collaboration, Shields has a vested interest in delivering measurable clinical and financial results for health systems. For more, visit our blog and follow us on social media, @ShieldsRX, LinkedIn, Facebook, and YouTube. Shields Health Solutions is a wholly owned subsidiary of Walgreens Boots Alliance and employs more than 2,000 people across the country.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 days ago
- CNBC
Actor Brooke Shields: I started my first business at age 59, and it's 'not for the meek of heart'
At age 59, Brooke Shields added a new title to her resume: CEO. The longtime actor and model launched a haircare line called Commence, aimed at women over the age of 40, in June 2024 — and as a first-time startup founder and CEO, she was quickly humbled, she said on May 28 at The Wall Street Journal's Future of Everything live event. "It is so not for the meek of heart," said Shields, now 60, adding: "Every step of the way you're just going, 'I can't believe I've done this." Shields recalled meeting with a venture capitalist in hopes that he'd invest in her startup, for example. He wasted no time telling her that she'd fail in the heavily saturated market of celebrity beauty brands, she said. "I said, 'You know what? I can stop you right there ... I'm not here for your opinion, I'm here for your money,'" said Shields. To her surprise, the gutsy move earned her some respect, she noted. And though he ultimately didn't give her any money — the business was too small — Shields said she was proud of herself for speaking up. "We'll go back [to pitch him again]," she a startup cost more money than Shields expected, so she raised roughly $3.5 million from outside investors to fund the launches of her company's first three products, Forbes reported on August 2. Similarly, at the Journal's event, she spoke about the unexpected skills you need to succeed as an entrepreneur — ones you might not know if you've never done it before. Building a strong team is only the start, she said: You need endurance and resilience to recover from setbacks, which will inevitably happen, and stand apart from your competitors. "You have to be really clear about your vision, your mission, and you have to really be clear that you can find a way to differentiate yourself," said Shields. Shields referred to Commence's target demographic as an example of a differentiating factor: As she aged, she noticed that her many of her peers felt like menopause and wrinkles made them feel less worthy as people, compared to when they were younger, she said. She saw an opening in the market. Gen Xers spend $279 billion per year on beauty goods, according to a January report. That number is expected to grow to $430 billion in the next 10 years, Shields said. Launching a startup is typically very challenging: Roughly 20% of new businesses fail within their first year, according to data from the U.S. Bureau of Labor Statistics. But don't let the belief that you've already peaked in life, or your doubts about succeeding, stop you from taking the risk, she advised. "I would tell someone, just don't give up," said Shields. "You've got to just be avaricious, and if you start doubting, just do something that absolutely stops you and keep moving forward. Be ready to pivot and be ready to surround yourself [with] the best [talent] that you can find to support the whole team." Successful entrepreneurs including Mark Cuban and Jeff Bezos have given similar advice over the years. "View setbacks as helpful obstacles that drive learning," Bezos wrote in an October 2021 social media post. "Whatever your goals are, don't give up no matter how hard it gets." ,
CNBC
3 days ago
- CNBC
Supreme Court rejects Mexico's lawsuit against U.S. gun makers
WASHINGTON — The Supreme Court on Thursday threw out the Mexican government's lawsuit against U.S. firearms manufacturers accusing them of aiding and abetting gun violence. The court ruled unanimously in a ruling authored by Justice Elena Kagan that the lawsuit is barred by a 2005 federal law that shields gun companies from legal liability. The 2021 lawsuit accused Smith & Wesson, Colt and other companies of deliberately selling guns to dealers who sell products that are frequently recovered at Mexican crime scenes. The Mexican government accused the companies of "aiding and abetting" violations of U.S. law, which they had argued means the gun makers were not protected by the federal immunity shield, called the Protection of Lawful Commerce in Arms Act. Mexico is seeking up to $10 billion in damages. The case at the Supreme Court involved two companies — Smith & Wesson and Interstate Arms. Other manufacturers, including Glock and Colt, successfully had claims against them tossed out. A federal judge initially ruled for the manufacturers, but the Boston-based 1st U.S. Circuit Court of Appeals revived the case last year, saying the liability shield did not extend to Mexico's specific claims. The case reached the Supreme Court following increased tensions between American and Mexican leaders after the election of President Donald Trump, who has cited drug trafficking and gang violence in Mexico amid his crackdown on illegal immigrants. Democrats in Congress have introduced legislation intended to reduce the flow of guns across the border, which they estimate to total at least 200,000 a year.
Yahoo
3 days ago
- Yahoo
Supreme Court spares US gun companies from Mexico's lawsuit
By John Kruzel and Andrew Chung WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday spared two American gun companies from a lawsuit by Mexico's government accusing them of aiding illegal firearms trafficking to drug cartels and fueling gun violence in the southern neighbor of the United States. The justices in a 9-0 ruling overturned a lower court's ruling that had allowed the lawsuit to proceed against firearms maker Smith & Wesson and distributor Interstate Arms. The lower court had found that Mexico plausibly alleged that the companies aided and abetted illegal gun sales, harming its government. The companies had argued for the dismissal of Mexico's suit, filed in Boston in 2021, under a 2005 U.S. law called the Protection of Lawful Commerce in Arms Act that broadly shields gun companies from liability for crimes committed with their products. The Boston-based 1st U.S. Circuit Court of Appeals decided in 2024 that the alleged conduct by the companies fell outside these protections. "Mexico alleges that the companies aided and abetted unlawful sales routing guns to Mexican drug cartels. The question presented is whether Mexico's complaint plausibly pleads that conduct. We conclude it does not," liberal Justice Elena Kagan wrote for the court. The case came to the Supreme Court at a complicated time for U.S.-Mexican relations as President Donald Trump pursues on-again, off-again tariffs on Mexican goods. Trump has also accused Mexico of doing too little to stop the flow of synthetic drugs such as fentanyl and migrant arrivals at the border. Mexico's lawsuit, filed in Boston in 2021, accused the two companies of violating various U.S. and Mexican laws. Mexico claims that the companies have deliberately maintained a distribution system that included firearms dealers who knowingly sell weapons to third-party, or "straw," purchasers who then traffic guns to cartels in Mexico. The suit also accused the companies of unlawfully designing and marketing their guns as military-grade weapons to drive up demand among the cartels, including by associating their products with the American military and law enforcement. The gun companies said they make and sell lawful products. To avoid its lawsuit being dismissed under the 2005 law, Mexico was required to plausibly allege that the companies aided and abetted illegal gun sales and that such conduct was the "proximate cause" - a legal principle involving who is responsible for causing an injury - of the harms claimed by Mexico. Mexico in the lawsuit sought monetary damages of an unspecified amount and a court order requiring Smith & Wesson and Interstate Arms to take steps to "abate and remedy the public nuisance they have created in Mexico." Gun violence fueled by trafficked U.S.-made firearms has contributed to a decline in business investment and economic activity in Mexico and forced its government to incur unusually high costs on services including healthcare, law enforcement and the military, according to the lawsuit. Mexico, a country with strict firearms laws, has said most of its gun homicides are committed with weapons trafficked from the United States and valued at more than $250 million annually. The Supreme Court heard arguments in the case on March 4.
